# Task C09: Synthesis of an anti-fungal

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2020 · $550,294

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10250577
- **Project number:** 272201800008I-0-759302000003-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** GREGORY MARTIN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $550,294
- **Award type:** —
- **Project period:** 2020-08-27 → 2021-06-04

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10250577

## Citation

> US National Institutes of Health, RePORTER application 10250577, Task C09: Synthesis of an anti-fungal (272201800008I-0-759302000003-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10250577. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*